Inventor · disambiguated record
Palani Balu
Also filed as: BALU PALANI
14 granted patents·13 pending applications·184 citations·filing 1999–2025
93Inventor score
Files withAFFYMAX INC8AVIDITY BIOSCIENCES INC8HOLMES CHRISTOPHER P3AVIDITY BIOSCIENCES LLC1CWIRLA STEVEN E1
Top patents by PatentIndex Score
27 records- 0198US10787519B2Nucleic acid-polypeptide compositions and uses thereofAVIDITY BIOSCIENCES INC·Filed 2018·Granted Sep 29, 2020·19 cites·17 claims
- 0298US10550188B2Nucleic acid-polypeptide compositions and uses thereofAVIDITY BIOSCIENCES INC·Filed 2018·Granted Feb 4, 2020·80 cites·13 claims
- 0397US10487149B2Nucleic acid-polypeptide compositions and uses thereofAVIDITY BIOSCIENCES INC·Filed 2018·Granted Nov 26, 2019·21 cites·18 claims
- 0495US10800848B2Nucleic acid-polypeptide compositions and uses thereofAVIDITY BIOSCIENCES INC·Filed 2018·Granted Oct 13, 2020·7 cites·16 claims
- 0581US7855175B2Peptides that bind to the erythropoietin receptorAFFYMAX INC·Filed 2008·Granted Dec 21, 2010·3 cites·12 claims
- 0681US6716811B1Compounds having affinity for the granulocyte-colony stimulating factor receptor (G-CSFR) and associated usesAFFYMAX INC·Filed 2000·Granted Apr 6, 2004·9 cites·7 claims
- 0779US12351637B2Nucleic acid-polypeptide compositions and uses thereofAVIDITY BIOSCIENCES INC·Filed 2021·Granted Jul 8, 2025·0 cites·15 claims
- 0879US12234290B2Nucleic acid-polypeptide compositions and uses thereofAVIDITY BIOSCIENCES INC·Filed 2021·Granted Feb 25, 2025·0 cites·23 claims
- 0978US7459522B2Peptide dimers as agonists of the erythropoietin (EPO) receptor, and associated methods of synthesis and useAFFYMAX INC·Filed 2003·Granted Dec 2, 2008·4 cites·13 claims
- 1078US2025171544A1Nucleic acid-polypeptide compositions and uses thereofAVIDITY BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 1175US6703480B1Peptide dimers as agonists of the erythropoientin (EPO) receptor, and associated methods of synthesis and useFiled 1999·Granted Mar 9, 2004·24 cites·8 claims
- 1275US2020123261A1Nucleic acid-polypeptide compositions and uses thereofAVIDITY BIOSCIENCES INC·Filed 2019·Application pending·0 cites
- 1373US9163227B2Anti-diabetic compoundsPFIZER·Filed 2012·Granted Oct 20, 2015·4 cites·14 claims
- 1470US8729030B2Peptides that bind to the erythropoietin receptorHOLMES CHRISTOPHER P·Filed 2010·Granted May 20, 2014·1 cites·22 claims
- 1569US2017281795A1Nucleic acid-polypeptide compositions and uses thereofAVIDITY BIOSCIENCES LLC·Filed 2017·Application pending·0 cites
- 1664US2009246225A1Methods of Producing Influenza Vaccine CompositionsMEDIMMUNE LLC·Filed 2008·Application pending·0 cites
- 1759US2007161085A1Methods of Producing Influenza Vaccine CompositionsMEDLMMUNE VACCINES INC·Filed 2007·Application pending·0 cites
- 1858US2005277588A1Compounds having affinity for the granulocyte-colony stimulating factor receptor (G-CSFR) and associated usesCWIRLA STEVEN E·Filed 2004·Application pending·0 cites
- 1957US2008108564A1Novel peptides that bind to the erythropoietin receptorAFFYMAX INC·Filed 2007·Application pending·0 cites
- 2056US2005037959A1Compounds having affinity for the granulocyte-colony stimulating factor receptor (G-CSFR) and associated usesFiled 2003·Application pending·0 cites
- 2154US7482433B2Peptides and compounds that bind to the IL-5 receptorAFFYMAX INC·Filed 2006·Granted Jan 27, 2009·0 cites·14 claims
- 2253US7109299B1Peptides and compounds that bind to the IL-5 receptorAFFYMAX INC·Filed 1999·Granted Sep 19, 2006·12 cites·24 claims
- 2352US2013012685A1Novel peptides that bind to the erythropoietin receptorAFFYMAX INC·Filed 2012·Application pending·0 cites
- 2451US2006014680A1Peptides and compounds that bind to the IL-5 receptorXU CAIDING·Filed 2004·Application pending·0 cites
- 2550US2011282029A1Novel peptides that bind to the erythropoietin receptorHOLMES CHRISTOPHER P·Filed 2010·Application pending·0 cites
- 2649US2009005292A1Novel Peptides that Bind to the Erythropoietin ReceptorAFFYMAX INC·Filed 2005·Application pending·0 cites
- 2741US2012157660A1Novel peptides that bind to the erythropoietin receptorHOLMES CHRISTOPHER P·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →